Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: carl w. trygstad who wrote (36)	10/23/1997 1:49:00 PM
From: THE LEPRECHAUN	Respond to of 359

Could you ask them what the significant differences are between their technology and Acadia's ????!!!!! thanks in advance

To: carl w. trygstad who wrote (36)	10/23/1997 3:16:00 PM
From: Biomaven	Read Replies (2) \| Respond to of 359

I'm taking a look at this stock, but have no position as yet. Can anybody comment on how its technology compares with IGEN's? IGEN just won a screening contract with Agouron: biz.yahoo.com My big concern with ABSC is that it looks to me like there's a big overhang of around 10m shares that hasn't been released from a 180 day lockup (after the IPO) yet. I generally tend to avoid stocks with a big overhang until a few months after the lockup is over. My suspicion is that there can sometimes even be pressure _ahead_ of the lockup release if the underwriters know (or strongly suspect) there are going to be substantial sales when the lockup ends. Peter